VIRACTA SUBSIDIARY, INC.

Profile

Company Names

VIRACTA SUBSIDIARY, INC.
VIRACTA THERAPEUTICS, INC.
HEMAQUEST PHARMACEUTICALS, INC.
HEMAQUEST PHARMACEUTICALS

Addresses

2533 S. COAST HIGHWAY 101, SUITE 210, CARDIFF, CA 92007

2533 S. COAST HIGHWAY 101, SUITE 210, CARDIFF, CA 92007

4747 EXECUTIVE DRIVE, SUITE 700, SAN DIEGO, CA 92121

11995 EL CAMINO REAL, SUITE 302, SAN DIEGO, CA 92130

1229 MADISON STREET, SUITE 680, SEATTLE, WA 98104

Phone Numbers

(858) 771-4190
8584008470
619 992 6111
(206) 682-1233

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY, PHARMACEUTICALS

Year Incorporated:

2007

State Incorporated:

DELAWARE

Total Amount Raised:

$173,309,608.00

Number of Funding Rounds:

9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2021-02-24 
$64,999,994.00 
$64,999,994.00 
$0.00 
Equity 
8
2020-11-25 
$39,999,997.00 
$40,000,000.00 
$3.00 
Equity 
7
2019-10-24 
$16,774,987.00 
$24,999,999.00 
$8,225,012.00 
Equity 
6
2019-01-31 
$5,714,363.00 
$5,714,363.00 
$0.00 
Equity 
5
2018-11-30 
$10,695,495.00 
$10,695,495.00 
$0.00 
Equity 
4
2018-06-18 
$2,685,000.00 
$8,500,000.00 
$5,815,000.00 
Debt 
3
2017-03-23 
$9,875,623.00 
$26,875,622.00 
$16,999,999.00 
Equity 
2
2012-03-07 
$6,499,999.00 
$16,000,000.00 
$9,500,001.00 
Equity 
1
2010-01-19 
$16,064,150.00 
$16,124,045.00 
$59,895.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RONALD 
 
BERENSON 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
DANIEL 
 
CHEVALLARD 
EXECUTIVE OFFICER
FRED 
 
DOTZLER 
DIRECTOR
FREDERICK 
 
DOTZLER 
DIRECTOR
BRYAN 
 
DUNNIVANT 
EXECUTIVE OFFICER, DIRECTOR
STANDISH 
 
FLEMING 
DIRECTOR
RICHARD 
 
GHALIE 
DIRECTOR, EXECUTIVE OFFICER
MARK 
 
HANDFELT 
EXECUTIVE OFFICER
JOHN 
P. 
LONGENECKER 
EXECUTIVE OFFICER, DIRECTOR
NAHEED 
 
MISFELDT 
DIRECTOR
SAMUEL 
 
MURPHY 
DIRECTOR
SUSAN 
 
PERRINE 
EXECUTIVE OFFICER
TAMARA 
 
SEYMOUR 
EXECUTIVE OFFICER
DAVID 
 
SLACK 
EXECUTIVE OFFICER
GEORGE 
 
STAMATOYANNOPOULOS 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-11-25 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-10-24 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-01-31 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-11-30 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2018-06-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-03-23 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2012-03-07 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-19 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2010-01-19 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#